BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38731613)

  • 1. Structure-Based Design of Novel Thiazolone[3,2-
    Zhu XD; Corona A; Maloccu S; Tramontano E; Wang S; Pannecouque C; De Clercq E; Meng G; Chen FE
    Molecules; 2024 May; 29(9):. PubMed ID: 38731613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of Thiazolo[3, 2-a]Pyrimidine derivatives as novel RNase H inhibitors.
    Zhao KX; Zhang YY; Wang JS; Wang S; Corona A; Maloccu S; Tramontano E; Pannecouque C; De Clercq E; Meng G; Wang L; Chen FE
    Bioorg Chem; 2024 Jul; 148():107495. PubMed ID: 38805850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.
    Corona A; Onnis V; Deplano A; Bianco G; Demurtas M; Distinto S; Cheng YC; Alcaro S; Esposito F; Tramontano E
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2,4-Triazolo[1,5-
    Desantis J; Massari S; Corona A; Astolfi A; Sabatini S; Manfroni G; Palazzotti D; Cecchetti V; Pannecouque C; Tramontano E; Tabarrini O
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32151066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors.
    Corona A; Desantis J; Massari S; Distinto S; Masaoka T; Sabatini S; Esposito F; Manfroni G; Maccioni E; Cecchetti V; Pannecouque C; Le Grice SF; Tramontano E; Tabarrini O
    ChemMedChem; 2016 Aug; 11(16):1709-20. PubMed ID: 26990134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.
    Sun L; Gao P; Dong G; Zhang X; Cheng X; Ding X; Wang X; Daelemans D; De Clercq E; Pannecouque C; Menéndez-Arias L; Zhan P; Liu X
    Eur J Med Chem; 2018 Jul; 155():714-724. PubMed ID: 29940462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase.
    Tang J; Vernekar SKV; Chen YL; Miller L; Huber AD; Myshakina N; Sarafianos SG; Parniak MA; Wang Z
    Eur J Med Chem; 2017 Jun; 133():85-96. PubMed ID: 28384548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV-1 RNase H inhibitors.
    Gao P; Wang X; Sun L; Cheng X; Poongavanam V; Kongsted J; Álvarez M; Luczkowiak J; Pannecouque C; De Clercq E; Lee KH; Chen CH; Liu H; Menéndez-Arias L; Liu X; Zhan P
    Chem Biol Drug Des; 2019 Apr; 93(4):582-589. PubMed ID: 30560566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach.
    Costi R; Métifiot M; Esposito F; Cuzzucoli Crucitti G; Pescatori L; Messore A; Scipione L; Tortorella S; Zinzula L; Novellino E; Pommier Y; Tramontano E; Marchand C; Di Santo R
    J Med Chem; 2013 Nov; 56(21):8588-98. PubMed ID: 24124919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action.
    Esposito F; Mandrone M; Del Vecchio C; Carli I; Distinto S; Corona A; Lianza M; Piano D; Tacchini M; Maccioni E; Cottiglia F; Saccon E; Poli F; Parolin C; Tramontano E
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28637198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold.
    Williams PD; Staas DD; Venkatraman S; Loughran HM; Ruzek RD; Booth TM; Lyle TA; Wai JS; Vacca JP; Feuston BP; Ecto LT; Flynn JA; DiStefano DJ; Hazuda DJ; Bahnck CM; Himmelberger AL; Dornadula G; Hrin RC; Stillmock KA; Witmer MV; Miller MD; Grobler JA
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6754-7. PubMed ID: 20869872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closely related antiretroviral agents as inhibitors of two HIV-1 enzymes, ribonuclease H and integrase: "killing two birds with one stone".
    Andréola ML
    Curr Pharm Des; 2004; 10(30):3713-23. PubMed ID: 15579066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV-1 RNase H inhibitors.
    Lansdon EB; Liu Q; Leavitt SA; Balakrishnan M; Perry JK; Lancaster-Moyer C; Kutty N; Liu X; Squires NH; Watkins WJ; Kirschberg TA
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2905-15. PubMed ID: 21464257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H.
    Marchand C; Beutler JA; Wamiru A; Budihas S; Möllmann U; Heinisch L; Mellors JW; Le Grice SF; Pommier Y
    Antimicrob Agents Chemother; 2008 Jan; 52(1):361-4. PubMed ID: 17967911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity.
    Wang L; Tang J; Huber AD; Casey MC; Kirby KA; Wilson DJ; Kankanala J; Xie J; Parniak MA; Sarafianos SG; Wang Z
    Eur J Med Chem; 2018 Aug; 156():652-665. PubMed ID: 30031976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of Active-Site Inhibitor Interaction with HIV-1 RNase H.
    Xi Z; Wang Z; Sarafianos SG; Myshakina NS; Ishima R
    ACS Infect Dis; 2019 Nov; 5(11):1963-1974. PubMed ID: 31577424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versatile anti-infective properties of pyrido- and dihydropyrido[2,3-d]pyrimidine-based compounds.
    Al Nasr IS; Corona A; Koko WS; Khan TA; Ben Said R; Daoud I; Rahali S; Tramontano E; Schobert R; Amdouni N; Biersack B
    Bioorg Med Chem; 2023 Jul; 90():117376. PubMed ID: 37336083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase.
    Messore A; Corona A; Madia VN; Saccoliti F; Tudino V; De Leo A; Ialongo D; Scipione L; De Vita D; Amendola G; Novellino E; Cosconati S; Métifiot M; Andreola ML; Esposito F; Grandi N; Tramontano E; Costi R; Di Santo R
    J Med Chem; 2021 Jun; 64(12):8579-8598. PubMed ID: 34106711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivatives of 5-nitro-furan-2-carboxylic acid carbamoylmethyl ester inhibit RNase H activity associated with HIV-1 reverse transcriptase.
    Fuji H; Urano E; Futahashi Y; Hamatake M; Tatsumi J; Hoshino T; Morikawa Y; Yamamoto N; Komano J
    J Med Chem; 2009 Mar; 52(5):1380-7. PubMed ID: 19178289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the research of HIV-1 RNase H inhibitors.
    Yu F; Liu X; Zhan P; De Clercq E
    Mini Rev Med Chem; 2008 Oct; 8(12):1243-51. PubMed ID: 18855738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.